- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02562885
Effect of Auditory Stimulation on Spike Waves in Sleep (ECLASS)
Effect of Closed-loop Auditory Stimulation on Spike Waves During Slow Wave Sleep, an Open Label Pilot Study
Background: Close relationship exists between sleep slow wave (SSW) and the generation of spike wave in NREM-sleep. SSW are cortically generated oscillations alternating between excitatory depolarization ("Up-phase" of the SSW) and inhibitory hyperpolarization ("Down-phase" of the SSW). It has been shown experimentally that with increasing synchrony of slow neuronal oscillations SSW turn into spike waves. Acoustic pulses applied in correspondence to the SSW "Up-phase" enhance the amplitude of the subsequent SSW. Conversely, tones delivered at the SSW "Downphase" have a disruptive effect on the following SSW.
Participants: Patients with epilepsy and spike waves in NREM-sleep.
Objective: Modification of spike wave frequency, amplitude and spreading during NREM sleep by acoustic pulses applied at the "Up-" or "Down-phase" of SSW.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zurich, Switzerland, CH-8032
- Div. of Clinical Neurophysiology/Epilepsy, University Children's Hospital Zurich
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants with Rolandic epilepsy/BECTS
- Participants with ESES/CSWS
- Participants with generalized spike waves in sleep
- EEG within 6 months before study night consistent with the diagnosis
Exclusion Criteria:
- Clinically significant concomitant acute or chronic disease
- Seizure frequency >1/week, history of convulsive status epilepticus or seizures provoked by sleep deprivation
- Severe sleep problems
- Treatment with corticosteroids, immunosuppressive or vagus nerve stimulation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Acoustic pulses
During NREM sleep:
Two different protocols are applied: (A) tone application at the "Down-phase" of sleep slow wave (SSW) (B) tone application at the "Up-phase" of SSW. Participants with Rolandic epilepsy/BECTS or generalized spike waves: Protocol A and B alternatingly. Participants with ESES/CSWS: only Protocol A. |
Acoustic pulses applied during NREM sleep slow waves "Up-phase" or "Down-phase".
The acoustic stimulus will be delivered by speakers with a volume of about 50 dB.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Spike wave index
Time Frame: Change baseline (without) and with acoustic pulses in the same NREM period: 45 minutes
|
Change of spike wave index during acoustic pulses applied at the "Up-" or "Down-phase" of sleep slow waves.
Spike wave index given in percent and calculated by number of seconds within 10 second windows with spike waves over the whole 15 minutes of the block design part.
|
Change baseline (without) and with acoustic pulses in the same NREM period: 45 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Spike wave amplitude
Time Frame: Change baseline (without) and with acoustic pulses in the same NREM period: 45 minutes
|
Change of spike wave amplitude (in microvolts) during acoustic pulses applied at the "Up-" or "Down-phase" of sleep slow waves.
Amplitudes of maximum spike will be analyzed in 10 seconds periods of the first and the last 100 seconds of every part of the block design.
EEG source derivation will be used for the analysis.
The mean of the 3 highest amplitudes of each 10 seconds period will be determined and the mean of the 10 periods will presented in mean and SD.
|
Change baseline (without) and with acoustic pulses in the same NREM period: 45 minutes
|
Spike wave spreading
Time Frame: Change baseline (without) and with acoustic pulses in the same NREM period: 45 minutes
|
Change of spike wave spreading during acoustic pulses applied at the "Up-" or "Down-phase" of sleep slow waves.
Spreading will be analyzed in 10 seconds periods of the first and the last 100 seconds of every part of the block design.
EEG source derivation will be used for the analysis.
Maximum spike wave spreading (number of electrodes involved) visible in 3 spike waves of each 10 second period will be determined and the mean of the 10 periods will presented in mean and SD.
|
Change baseline (without) and with acoustic pulses in the same NREM period: 45 minutes
|
Spike wave index in the NREM (2) period following the NREM (1) period with acoustic pulses
Time Frame: Change baseline (NREM 1) and NREM 2: expected average of 1 hour
|
Change of spike wave index in the NREM period following the NREM period with acoustic pulses applied at the "Up-" or "Down-phase" of sleep slow waves.
Over the first 15 minutes of the following NREM period: Spike wave index given in percent and calculated by number of seconds within 10 second windows with spike waves .
|
Change baseline (NREM 1) and NREM 2: expected average of 1 hour
|
Spike wave amplitude in the NREM (2) period following the NREM (1) period with acoustic pulses
Time Frame: Change baseline (NREM 1) and NREM 2: expected average of 1 hour
|
Change of spike wave amplitude (in microvolts) in the NREM period following the NREM period with acoustic pulses applied at the "Up-" or "Down-phase" of sleep slow waves.
Amplitudes of maximum spike will be analyzed in 10 seconds periods of the first and the last 100 seconds of the following NREM period.
EEG source derivation will be used for the analysis.
The mean of the 3 highest amplitudes of each 10 seconds period will be determined and the mean of the 10 periods will presented in mean and SD.
|
Change baseline (NREM 1) and NREM 2: expected average of 1 hour
|
Spike wave spreading in the NREM (2) period following the NREM (1) period with acoustic pulses
Time Frame: Change baseline (NREM 1) and NREM 2: expected average of 1 hour
|
Change of spike wave spreading in the NREM period following the NREM period with acoustic pulses applied at the "Up-" or "Down-phase" of sleep slow waves.
Spreading will be analyzed in 10 seconds periods of the first and the last 100 seconds of the following NREM period.
EEG source derivation will be used for the analysis.
Maximum spike wave spreading (number of electrodes involved) visible in 3 spike waves of each 10 second period will be determined and the mean of the 10 periods will presented in mean and SD.
|
Change baseline (NREM 1) and NREM 2: expected average of 1 hour
|
Collaborators and Investigators
Investigators
- Principal Investigator: Bernhard Schmitt, MD, Div. of Clinical Neurophysiology/Epilepsy, University Children's Hospital, Steinwiesstrasse 75, CH-8032 Zurich
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SW2015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Epilepsy
-
NaviFUS CorporationTaipei Veterans General Hospital, TaiwanCompletedDrug Resistant Epilepsy | Epilepsy, Drug Resistant | Intractable Epilepsy | Refractory Epilepsy | Drug Refractory Epilepsy | Epilepsy, Drug Refractory | Epilepsy, Intractable | Medication Resistant EpilepsyTaiwan
-
Great Ormond Street Hospital for Children NHS Foundation...Active, not recruitingEpilepsies, Partial | Intractable Epilepsy | Focal Epilepsy | Refractory Epilepsy | Epilepsy Intractable | Epilepsy in Children | Epilepsy, FocalUnited Kingdom
-
University of British ColumbiaTerminatedJuvenile Myoclonic Epilepsy | Childhood Absence Epilepsy | Juvenile Absence EpilepsyCanada
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Neuroelectrics CorporationRecruitingEpilepsy | Seizures | Refractory Epilepsy | Epilepsy, Tonic-Clonic | Epilepsy in Children | Seizures, Focal | Focal SeizureSpain, United States, France, Belgium
-
Oslo University HospitalCompletedEpilepsy | Generalized Epilepsy | Focal EpilepsyNorway
-
UCB Pharma SACompletedEpilepsy, Tonic-clonicPoland, Sweden, Hungary, Czechia
-
UCB PharmaCompletedEpilepsy, Tonic-clonic
-
University Hospital, LilleUnknownFocal Epilepsy | Epilepsy IntractableFrance
-
Xuanwu Hospital, BeijingPeking University; Beijing Tiantan Hospital; Qilu Hospital of Shandong University and other collaboratorsNot yet recruitingEpilepsy, Drug ResistantChina
Clinical Trials on Acoustic pulses
-
Oklahoma State UniversityUSDA Beltsville Human Nutrition Research CenterCompleted
-
St. Boniface HospitalUniversity of ManitobaCompletedPeripheral Arterial DiseaseCanada
-
University of TurkuCompletedUnidentified Gastrointestinal Symptoms Following Pulses ConsumptionFinland
-
Creighton UniversityCompletedRadial Artery OcclusionUnited States
-
Hospices Civils de LyonUnknown
-
Assistance Publique - Hôpitaux de ParisUniversity of Paris 5 - Rene DescartesCompleted
-
ANM Adaptive Neuromodulation GmbHCompletedChronic Tonal TinnitusGermany
-
Paola VitaglioneRecruitingLifestyle-related ConditionItaly
-
LightGuardSuspended
-
John SievenpiperCanadian Institutes of Health Research (CIHR); Canada Research Chairs Endowment... and other collaboratorsUnknownHypertension | Obesity | Cardiovascular Disease | Diabetes | Overweight | Metabolic Syndrome | Dyslipidemia | Prediabetes | DysglycemiaCanada